How ALung got on a London medical device manufacturer's radar

The May 2 sale resulted in LivaNova acquiring the remaining 97% equity stake in ALung.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 10, 2022 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news